680 related articles for article (PubMed ID: 35501370)
21. Regulation of cGAS-STING signalling in cancer: Approach for combination therapy.
Vasiyani H; Wadhwa B; Singh R
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188896. PubMed ID: 37088059
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cGAS and STING signaling during inflammation and infection.
Chauvin SD; Stinson WA; Platt DJ; Poddar S; Miner JJ
J Biol Chem; 2023 Jul; 299(7):104866. PubMed ID: 37247757
[TBL] [Abstract][Full Text] [Related]
23. [Mitochondrial DNA and cGAS-STING Innate Immune Signaling Pathway: Latest Research Progress].
Li YX; Cui SF; Meng W; Hu HY; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):387-395. PubMed ID: 34018355
[TBL] [Abstract][Full Text] [Related]
24. Role of the cGAS-STING pathway in systemic and organ-specific diseases.
Skopelja-Gardner S; An J; Elkon KB
Nat Rev Nephrol; 2022 Sep; 18(9):558-572. PubMed ID: 35732833
[TBL] [Abstract][Full Text] [Related]
25. cGAS-STING pathway: post-translational modifications and functions in sterile inflammatory diseases.
Hong Z; Ma T; Liu X; Wang C
FEBS J; 2022 Oct; 289(20):6187-6208. PubMed ID: 34310043
[TBL] [Abstract][Full Text] [Related]
26. Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases.
Pan J; Fei CJ; Hu Y; Wu XY; Nie L; Chen J
Zool Res; 2023 Jan; 44(1):183-218. PubMed ID: 36579404
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial DNA release mediated by TFAM deficiency promotes copper-induced mitochondrial innate immune response via cGAS-STING signalling in chicken hepatocytes.
Li Q; Wang S; Guo P; Feng Y; Yu W; Zhang H; Guo J; Li Y; Hu L; Pan J; Liao J; Tang Z
Sci Total Environ; 2023 Dec; 905():167315. PubMed ID: 37742962
[TBL] [Abstract][Full Text] [Related]
28. Conserved strategies for pathogen evasion of cGAS-STING immunity.
Eaglesham JB; Kranzusch PJ
Curr Opin Immunol; 2020 Oct; 66():27-34. PubMed ID: 32339908
[TBL] [Abstract][Full Text] [Related]
29. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
[TBL] [Abstract][Full Text] [Related]
30. Control of innate immunity by the cGAS-STING pathway.
Mosallanejad K; Kagan JC
Immunol Cell Biol; 2022 Jul; 100(6):409-423. PubMed ID: 35485309
[TBL] [Abstract][Full Text] [Related]
31. Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer.
Loo TM; Miyata K; Tanaka Y; Takahashi A
Cancer Sci; 2020 Feb; 111(2):304-311. PubMed ID: 31799772
[TBL] [Abstract][Full Text] [Related]
32. Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway.
Dai P; Wang W; Cao H; Avogadri F; Dai L; Drexler I; Joyce JA; Li XD; Chen Z; Merghoub T; Shuman S; Deng L
PLoS Pathog; 2014 Apr; 10(4):e1003989. PubMed ID: 24743339
[TBL] [Abstract][Full Text] [Related]
33. RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing.
Webb LG; Fernandez-Sesma A
Curr Opin Virol; 2022 Apr; 53():101206. PubMed ID: 35180533
[TBL] [Abstract][Full Text] [Related]
34. Potential Therapeutic Value of the STING Inhibitors.
Zhang S; Zheng R; Pan Y; Sun H
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049889
[TBL] [Abstract][Full Text] [Related]
35. The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.
Storozynsky Q; Hitt MM
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238631
[TBL] [Abstract][Full Text] [Related]
36. The cGAS-STING Pathway in Bacterial Infection and Bacterial Immunity.
Liu N; Pang X; Zhang H; Ji P
Front Immunol; 2021; 12():814709. PubMed ID: 35095914
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of cGAS/STING activity during mitosis.
Uhlorn BL; Gamez ER; Li S; Campos SK
Life Sci Alliance; 2020 Sep; 3(9):. PubMed ID: 32661021
[TBL] [Abstract][Full Text] [Related]
38. Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS-cGAMP-STING Pathway.
Ritchie C; Carozza JA; Li L
Annu Rev Biochem; 2022 Jun; 91():599-628. PubMed ID: 35287475
[TBL] [Abstract][Full Text] [Related]
39. The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy.
Chen R; Liu M; Jiang Q; Meng X; Wei J
Front Immunol; 2023; 14():1121603. PubMed ID: 37153627
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of STING binding with and phosphorylation by TBK1.
Zhang C; Shang G; Gui X; Zhang X; Bai XC; Chen ZJ
Nature; 2019 Mar; 567(7748):394-398. PubMed ID: 30842653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
